期刊文献+

Ⅰ型氯吡格雷硫酸氢盐的合成工艺改进

Improved preparation method of crystalline form Ⅰ of clopidogrel hydrogen sulfate
下载PDF
导出
摘要 目的优化Ⅰ型氯吡格雷硫酸氢盐的合成工艺。方法以(R)-(-)-邻氯扁桃酸为原料,经甲酯化、磺酰化和亲核取代反应合成氯吡格雷,最后与浓硫酸反应生成氯吡格雷硫酸氢盐。结果新合成方法操作更加简便,总收率为58.3%。结论改进后的工艺便于纯化,更适应于工业化生产。 Objective To optimize the preparation of crystalline form Ⅰ clopidogrel hydrogen sulfate.Methods Clopidogrel was synthesized by esterification of the starting material 2-chloromandelic acid,and subsequent sulfonylation and nucleophilic substitution.Then the clopidogrel hydrogen sulfate was prepared by treatment with concentrated sulphuric acid.Results The total yield of clopidogrel hydrogen sulfate by the improved method was 58.3 %,and the operation was more convenient.Conclusion The improved synthesis process is convenient and cost-saving,and more suitable for industrial production.
出处 《新乡医学院学报》 CAS 2012年第12期955-957,共3页 Journal of Xinxiang Medical University
关键词 Ⅰ型氯吡格雷硫酸氢盐 邻氯扁桃酸 合成工艺 crystalline form Ⅰ of clopidogrel hydrogen sulfate 2-chloromandelic acid preparation method
  • 相关文献

参考文献10

二级参考文献115

  • 1韩素慧,邱春光,韩战营,张军,李晨.氯吡格雷对非ST段抬高型急性冠脉综合征患者心脏事件的影响[J].新乡医学院学报,2006,23(3):277-278. 被引量:3
  • 2韩文杰,文小军.诱生型一氧化氮合酶及一氧化氮对心脏的作用[J].新乡医学院学报,2006,23(6):644-646. 被引量:2
  • 3梁美好,沈正荣.(+)-氯吡格雷的合成工艺改进[J].中国药物化学杂志,2007,17(3):163-165. 被引量:12
  • 4肖作平.早期综合治疗急性缺血性脑血管病的进展[J].中国中西医结合急救杂志,2002,9(1):62-62,3.
  • 5Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance[J].JACC,2006,47 (1):27-33.
  • 6Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345(7):494-502.
  • 7Ben-Dor I,Kleiman NS,Lev E.Assessment,mechanisms,and clinical implication of variability in platelet response to aspirin and clopidogrel therapy[J].Am J Cardiol,2009,104(2):227-233.
  • 8Marcucci R,Gori AM,Paniccia R,et al.Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay.A 12-month follow-up[J].Circulation,2009,119(2):237-242.
  • 9Patti G,Nusca A,Mangiacapra F,et al.Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Platelet Reactivity Predicts Outcome) study[J].J Am Coll Cardiol,2008,52(14):1128-1133.
  • 10Bonello L,Paganelli F,Arpin-Bornet M,et al.Vasodilator-stimulated phospho-protein phosphorylation analysis prior to percutaneous coronary intervention forexclusion of postprocedural major adverse cardiovascular events[J].J ThrombHaemost,2007,5(8):1630-1636.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部